UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 7, 2017

 

Science Applications International Corporation

(Exact name of registrant as specified in its charter)

 

 

Delaware

 

001-35832

 

46-1932921

(State or other Jurisdiction

of Incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

12010 Sunset Hills Road, Reston, VA 20190

(Address of Principal Executive Offices) (Zip Code)

(703) 676-4300

Registrant’s telephone number, including area code

Not Applicable

(Former name or former address if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 

 

 

 


Item 5.07. Submission of Matters to a Vote of Security Holders

Science Applications International Corporation (the “Company”) held its virtual annual meeting of stockholders on June 7, 2017 (the “Annual Meeting”). The holders of 36,093,231 shares of common stock of the Company, or 82.58% of the outstanding shares entitled to vote as of the record date for the Annual Meeting, were represented at the Annual Meeting in person or by proxy.  The final voting results on each of the matters presented to stockholders for a vote is set forth below.

 

1.

The nominees to the Board of Directors of the Company were elected, each for a one-year term, based upon the following votes:

 

 

Number of Votes

Director Nominee

For

 

    

Against

 

    

Abstain

 

    

Broker

Non-Votes

Robert A. Bedingfield

 

30,826,802

  

    

 

397,802

  

    

 

189,270

  

    

 

4,679,357

Deborah B. Dunie

 

30,784,783

  

    

 

438,571

  

    

 

190,520

  

    

 

4,679,357

John J. Hamre

 

30,799,914

  

    

 

421,046

  

    

 

192,914

  

    

 

4,679,357

Timothy J. Mayopoulos

 

28,409,377

 

 

 

2,595,557

 

 

 

408,940

 

 

 

4,679,357

Anthony J. Moraco

 

30,936,886

  

    

 

346,760

  

    

 

130,228

  

    

 

4,679,357

Donna S. Morea

 

30,835,158

  

    

 

379,932

  

    

 

198,784

  

    

 

4,679,357

Edward J. Sanderson, Jr.

 

30,674,636

  

    

 

546,670

  

    

 

192,568

  

    

 

4,679,357

Steven R. Shane

 

30,846,277

  

    

 

369,028

  

    

 

198,569

  

    

 

4,679,357

 

2.

The proposal to approve, on a non-binding, advisory basis, the compensation of our named executive officers of the Company as disclosed in the Company’s proxy statement was approved based upon the following votes:

 

Number of Votes

For

  

30,303,495

Against

  

762,559

Abstain

  

347,820

Broker Non-Votes

  

4,679,357

 

3.

The proposal to ratify the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending February 2, 2018 was approved based upon the following votes:

 

Number of Votes

For

  

35,760,395

Against

  

245,774

Abstain

  

87,062

 

 


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: June 13, 2017

Science Applications International Corporation

 

By:

 

/s/ Steven G. Mahon

 

 

Steven G. Mahon

 

 

Executive Vice President, General Counsel and Corporate Secretary